{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T12:54:48Z","timestamp":1785416088009,"version":"3.56.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K17439"],"award-info":[{"award-number":["20K17439"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Neutrophil extracellular traps (NETs) are involved in systemic lupus erythematosus (SLE). We sought to cluster SLE patients based on serum NET levels. Serum NET levels were higher in SLE patients than healthy controls. Frequencies of pleuritis and myositis were increased in patients with high serum NET levels. Serum NET levels negatively correlated with anti\u2013double stranded DNA (anti-dsDNA) antibody titers and C1q-binding immune complexes, but positively correlated with C-reactive protein (CRP) and monocyte counts. Neutrophil transcriptome analysis demonstrated no difference in NET-associated signatures, irrespective of serum NET levels, suggesting anti-dsDNA antibody-mediated clearance of NETs. In serum, NET levels were significantly correlated with myeloid cell-derived inflammatory molecules. Serum NET-based cluster analysis revealed 3 groups of patients based on serum NET and CRP levels, anti-dsDNA antibody titers, and monocyte count. Monocytes were consistently activated following NET-containing immune complex (NET-IC) stimulation. In conclusion, SLE patients with high serum NET levels had lower anti-dsDNA antibody titers and higher inflammatory responses. NET-IC-stimulated monocytes might associate with an inflammatory response characterized by elevated CRP levels. These findings can apply to precision medicine, as inflammatory processes, rather than antibody-dependent processes, can be targeted in specific subpopulations of SLE patients.<\/jats:p>","DOI":"10.1038\/s41598-022-23076-1","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T11:03:06Z","timestamp":1667300586000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Serum extracellular traps associate with the activation of myeloid cells in SLE patients with the low level of anti-DNA antibodies"],"prefix":"10.1038","volume":"12","author":[{"given":"Norio","family":"Hanata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mineto","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Tsuchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Nagafuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Shoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keishi","family":"Fujio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"key":"23076_CR1","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos, G. C. Systemic lupus erythematosus. N. Engl. J. Med. 365, 2110\u20132121. https:\/\/doi.org\/10.1056\/NEJMra1100359 (2011).","journal-title":"N. Engl. J. Med."},{"key":"23076_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/0961203313512882","volume":"23","author":"EM Ball","year":"2014","unstructured":"Ball, E. M., Gibson, D. S., Bell, A. L. & Rooney, M. R. Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus. Lupus 23, 46\u201356. https:\/\/doi.org\/10.1177\/0961203313512882 (2014).","journal-title":"Lupus"},{"key":"23076_CR3","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3109\/s101650200049","volume":"12","author":"K Ueki","year":"2002","unstructured":"Ueki, K. et al. Extremely high levels of C-reactive protein in patients with acute lupus serositis. Mod. Rheumatol. 12, 267\u2013270. https:\/\/doi.org\/10.3109\/s101650200049 (2002).","journal-title":"Mod. Rheumatol."},{"key":"23076_CR4","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1177\/0961203318763732","volume":"27","author":"E Littlejohn","year":"2018","unstructured":"Littlejohn, E. et al. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever. Lupus 27, 1123\u20131129. https:\/\/doi.org\/10.1177\/0961203318763732 (2018).","journal-title":"Lupus"},{"key":"23076_CR5","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535. https:\/\/doi.org\/10.1126\/science.1092385 (2004).","journal-title":"Science"},{"key":"23076_CR6","doi-asserted-by":"publisher","DOI":"10.1172\/JCI144918","author":"S Gupta","year":"2021","unstructured":"Gupta, S. & Kaplan, M. J. Bite of the wolf: Innate immune responses propagate autoimmunity in lupus. J. Clin. Invest. https:\/\/doi.org\/10.1172\/JCI144918 (2021).","journal-title":"J. Clin. Invest."},{"key":"23076_CR7","doi-asserted-by":"publisher","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","volume":"3","author":"R Lande","year":"2011","unstructured":"Lande, R. et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra19. https:\/\/doi.org\/10.1126\/scitranslmed.3001180 (2011).","journal-title":"Sci. Transl. Med."},{"key":"23076_CR8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146\u2013153. https:\/\/doi.org\/10.1038\/nm.4027 (2016).","journal-title":"Nat. Med."},{"key":"23076_CR9","doi-asserted-by":"publisher","first-page":"15880","DOI":"10.1073\/pnas.1005743107","volume":"107","author":"TA Fuchs","year":"2010","unstructured":"Fuchs, T. A. et al. Extracellular DNA traps promote thrombosis. Proc. Natl. Acad. Sci. U. S. A. 107, 15880\u201315885. https:\/\/doi.org\/10.1073\/pnas.1005743107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"23076_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nm.1959","volume":"15","author":"K Kessenbrock","year":"2009","unstructured":"Kessenbrock, K. et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat. Med. 15, 623\u2013625. https:\/\/doi.org\/10.1038\/nm.1959 (2009).","journal-title":"Nat. Med."},{"key":"23076_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3389\/fimmu.2020.01095","volume":"11","author":"N Hanata","year":"2020","unstructured":"Hanata, N. et al. Peptidylarginine deiminase 4 promotes the renal infiltration of neutrophils and exacerbates the TLR7 agonist-induced lupus mice. Front. Immunol. 11, 1095. https:\/\/doi.org\/10.3389\/fimmu.2020.01095 (2020).","journal-title":"Front. Immunol."},{"key":"23076_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-020-08816-3","volume":"60","author":"Y Liu","year":"2021","unstructured":"Liu, Y. & Kaplan, M. J. Neutrophils in the pathogenesis of rheumatic diseases: Fueling the fire. Clin. Rev. Allergy Immunol. 60, 1\u201316. https:\/\/doi.org\/10.1007\/s12016-020-08816-3 (2021).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"23076_CR13","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-1162-3_9","volume":"2255","author":"M Tong","year":"2021","unstructured":"Tong, M. & Abrahams, V. M. Visualization and quantification of neutrophil extracellular traps. Methods Mol. Biol. 2255, 87\u201395. https:\/\/doi.org\/10.1007\/978-1-0716-1162-3_9 (2021).","journal-title":"Methods Mol. Biol."},{"key":"23076_CR14","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1016\/j.cell.2021.03.056","volume":"184","author":"M Ota","year":"2021","unstructured":"Ota, M. et al. Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases. Cell 184, 3006\u20133021. https:\/\/doi.org\/10.1016\/j.cell.2021.03.056 (2021).","journal-title":"Cell"},{"key":"23076_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg, M. C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40, 1725. https:\/\/doi.org\/10.1002\/art.1780400928 (1997).","journal-title":"Arthritis Rheum."},{"key":"23076_CR16","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri, M. et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 64, 2677\u20132686. https:\/\/doi.org\/10.1002\/art.34473 (2012).","journal-title":"Arthritis Rheum."},{"key":"23076_CR17","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1136\/annrheumdis-2019-215089","volume":"78","author":"A Fanouriakis","year":"2019","unstructured":"Fanouriakis, A. et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann. Rheum. Dis. 78, 736\u2013745. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215089 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"23076_CR18","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138999","author":"Y Zuo","year":"2020","unstructured":"Zuo, Y. et al. Neutrophil extracellular traps in COVID-19. JCI Insight https:\/\/doi.org\/10.1172\/jci.insight.138999 (2020).","journal-title":"JCI Insight"},{"key":"23076_CR19","doi-asserted-by":"publisher","first-page":"4117","DOI":"10.1038\/s41467-021-24360-w","volume":"12","author":"L Vanderbeke","year":"2021","unstructured":"Vanderbeke, L. et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat. Commun. 12, 4117. https:\/\/doi.org\/10.1038\/s41467-021-24360-w (2021).","journal-title":"Nat. Commun."},{"key":"23076_CR20","doi-asserted-by":"publisher","first-page":"25222","DOI":"10.1073\/pnas.1908576116","volume":"116","author":"P Mistry","year":"2019","unstructured":"Mistry, P. et al. Transcriptomic, epigenetic, and functional analyses implicate neutrophil diversity in the pathogenesis of systemic lupus erythematosus. Proc. Natl. Acad. Sci. U. S. A. 116, 25222\u201325228. https:\/\/doi.org\/10.1073\/pnas.1908576116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"23076_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-3335-8_16","volume":"1390","author":"KL Moody","year":"2016","unstructured":"Moody, K. L., Uccellini, M. B., Avalos, A. M., Marshak-Rothstein, A. & Viglianti, G. A. Toll-like receptor-dependent immune complex activation of B cells and dendritic cells. Methods Mol. Biol. 1390, 249\u2013272. https:\/\/doi.org\/10.1007\/978-1-4939-3335-8_16 (2016).","journal-title":"Methods Mol. Biol."},{"key":"23076_CR22","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1681\/ASN.2013060606","volume":"25","author":"D Nakazawa","year":"2014","unstructured":"Nakazawa, D. et al. Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. J. Am. Soc. Nephrol. 25, 990\u2013997. https:\/\/doi.org\/10.1681\/ASN.2013060606 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"23076_CR23","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim, A. et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl. Acad. Sci. U. S. A. 107, 9813\u20139818. https:\/\/doi.org\/10.1073\/pnas.0909927107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"23076_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080898","author":"A Alunno","year":"2019","unstructured":"Alunno, A., Padjen, I., Fanouriakis, A. & Boumpas, D. T. Pathogenic and therapeutic relevance of JAK\/STAT signaling in systemic lupus erythematosus: Integration of distinct inflammatory pathways and the prospect of their inhibition with an oral agent. Cells https:\/\/doi.org\/10.3390\/cells8080898 (2019).","journal-title":"Cells"},{"key":"23076_CR25","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/art.40180","volume":"69","author":"S Kubo","year":"2017","unstructured":"Kubo, S. et al. Peripheral immunophenotyping identifies three subgroups based on T cell heterogeneity in lupus patients. Arthritis Rheumatol. 69, 2029\u20132037. https:\/\/doi.org\/10.1002\/art.40180 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"23076_CR26","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1136\/annrheumdis-2018-214379","volume":"78","author":"NI Panousis","year":"2019","unstructured":"Panousis, N. I. et al. Combined genetic and transcriptome analysis of patients with SLE: Distinct, targetable signatures for susceptibility and severity. Ann. Rheum. Dis. 78, 1079\u20131089. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214379 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"23076_CR27","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s00281-013-0375-7","volume":"35","author":"C Carmona-Rivera","year":"2013","unstructured":"Carmona-Rivera, C. & Kaplan, M. J. Low-density granulocytes: A distinct class of neutrophils in systemic autoimmunity. Semin. Immunopathol. 35, 455\u2013463. https:\/\/doi.org\/10.1007\/s00281-013-0375-7 (2013).","journal-title":"Semin. Immunopathol."},{"key":"23076_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3899\/jrheum.181232","volume":"47","author":"M Bruschi","year":"2020","unstructured":"Bruschi, M. et al. Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis. J. Rheumatol. 47, 377\u2013386. https:\/\/doi.org\/10.3899\/jrheum.181232 (2020).","journal-title":"J. Rheumatol."},{"key":"23076_CR29","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1042\/bst0300978","volume":"30","author":"AM Blom","year":"2002","unstructured":"Blom, A. M. Structural and functional studies of complement inhibitor C4b-binding protein. Biochem. Soc. Trans. 30, 978\u2013982. https:\/\/doi.org\/10.1042\/bst0300978 (2002).","journal-title":"Biochem. Soc. Trans."},{"key":"23076_CR30","doi-asserted-by":"publisher","first-page":"23869","DOI":"10.1074\/jbc.C400159200","volume":"279","author":"L Kask","year":"2004","unstructured":"Kask, L., Trouw, L. A., Dahlback, B. & Blom, A. M. The C4b-binding protein-protein S complex inhibits the phagocytosis of apoptotic cells. J. Biol. Chem. 279, 23869\u201323873. https:\/\/doi.org\/10.1074\/jbc.C400159200 (2004).","journal-title":"J. Biol. Chem."},{"key":"23076_CR31","doi-asserted-by":"publisher","first-page":"4644","DOI":"10.1182\/blood-2010-01-263038","volume":"115","author":"A Buil","year":"2010","unstructured":"Buil, A. et al. C4BPB\/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies. Blood 115, 4644\u20134650. https:\/\/doi.org\/10.1182\/blood-2010-01-263038 (2010).","journal-title":"Blood"},{"key":"23076_CR32","doi-asserted-by":"publisher","first-page":"622326","DOI":"10.3389\/fimmu.2020.622326","volume":"11","author":"H Enocsson","year":"2020","unstructured":"Enocsson, H. et al. C-reactive protein levels in systemic lupus erythematosus are modulated by the interferon gene signature and CRP gene polymorphism rs1205. Front. Immunol. 11, 622326. https:\/\/doi.org\/10.3389\/fimmu.2020.622326 (2020).","journal-title":"Front. Immunol."},{"key":"23076_CR33","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1002\/art.41518","volume":"73","author":"KA Casey","year":"2021","unstructured":"Casey, K. A. et al. Modulation of cardiometabolic disease markers by type I interferon inhibition in systemic lupus erythematosus. Arthritis Rheumatol. 73, 459\u2013471. https:\/\/doi.org\/10.1002\/art.41518 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"23076_CR34","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41423-020-00591-7","volume":"18","author":"A Boufenzer","year":"2021","unstructured":"Boufenzer, A. et al. Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis. Cell Mol. Immunol. 18, 452\u2013460. https:\/\/doi.org\/10.1038\/s41423-020-00591-7 (2021).","journal-title":"Cell Mol. Immunol."},{"key":"23076_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1136\/annrheumdis-2017-212617","volume":"77","author":"A Barrera-Vargas","year":"2018","unstructured":"Barrera-Vargas, A. et al. Differential ubiquitination in NETs regulates macrophage responses in systemic lupus erythematosus. Ann. Rheum. Dis. 77, 944\u2013950. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212617 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"23076_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cells10102545","author":"J Torres-Ruiz","year":"2021","unstructured":"Torres-Ruiz, J. et al. Neutrophil extracellular traps contribute to COVID-19 hyperinflammation and humoral autoimmunity. Cells https:\/\/doi.org\/10.3390\/cells10102545 (2021).","journal-title":"Cells"},{"key":"23076_CR37","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1038\/s41467-021-23361-z","volume":"12","author":"SA Hasni","year":"2021","unstructured":"Hasni, S. A. et al. Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus. Nat. Commun. 12, 3391. https:\/\/doi.org\/10.1038\/s41467-021-23361-z (2021).","journal-title":"Nat. Commun."},{"key":"23076_CR38","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41586-022-04642-z","volume":"605","author":"GJ Brown","year":"2022","unstructured":"Brown, G. J. et al. TLR7 gain-of-function genetic variation causes human lupus. Nature 605, 349\u2013356. https:\/\/doi.org\/10.1038\/s41586-022-04642-z (2022).","journal-title":"Nature"},{"key":"23076_CR39","doi-asserted-by":"publisher","first-page":"73ra20","DOI":"10.1126\/scitranslmed.3001201","volume":"3","author":"GS Garcia-Romo","year":"2011","unstructured":"Garcia-Romo, G. S. et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci. Transl. Med. 3, 73ra20. https:\/\/doi.org\/10.1126\/scitranslmed.3001201 (2011).","journal-title":"Sci. Transl. Med."},{"key":"23076_CR40","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/intimm\/dxz036","volume":"31","author":"S Hirose","year":"2019","unstructured":"Hirose, S., Lin, Q., Ohtsuji, M., Nishimura, H. & Verbeek, J. S. Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis. Int. Immunol. 31, 687\u2013696. https:\/\/doi.org\/10.1093\/intimm\/dxz036 (2019).","journal-title":"Int. Immunol."},{"key":"23076_CR41","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.1093\/rheumatology\/keab893","volume":"61","author":"N Hanata","year":"2022","unstructured":"Hanata, N., Shoda, H., Tsuchida, Y., Nagafuchi, Y. & Fujio, K. Comment on: Neutrophil extracellular traps in giant cell arteritis biopsies: Presentation, localization and co-expression with inflammatory cytokines. Rheumatol. (Oxford) 61, e154\u2013e155. https:\/\/doi.org\/10.1093\/rheumatology\/keab893 (2022).","journal-title":"Rheumatol. (Oxford)"},{"key":"23076_CR42","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.3899\/jrheum.190875","volume":"47","author":"S Moore","year":"2020","unstructured":"Moore, S. et al. Role of neutrophil extracellular traps regarding patients at risk of increased disease activity and cardiovascular comorbidity in systemic lupus erythematosus. J. Rheumatol. 47, 1652\u20131660. https:\/\/doi.org\/10.3899\/jrheum.190875 (2020).","journal-title":"J. Rheumatol."},{"key":"23076_CR43","doi-asserted-by":"publisher","first-page":"e0250265","DOI":"10.1371\/journal.pone.0250265","volume":"16","author":"H Hayden","year":"2021","unstructured":"Hayden, H. et al. ELISA detection of MPO-DNA complexes in human plasma is error-prone and yields limited information on neutrophil extracellular traps formed in vivo. PLoS ONE 16, e0250265. https:\/\/doi.org\/10.1371\/journal.pone.0250265 (2021).","journal-title":"PLoS ONE"},{"key":"23076_CR44","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/art.41062","volume":"72","author":"M Bach","year":"2020","unstructured":"Bach, M. et al. A neutrophil activation biomarker panel in prognosis and monitoring of patients with rheumatoid arthritis. Arthritis Rheumatol. 72, 47\u201356. https:\/\/doi.org\/10.1002\/art.41062 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"23076_CR45","doi-asserted-by":"publisher","first-page":"41749","DOI":"10.1038\/srep41749","volume":"7","author":"MA Khan","year":"2017","unstructured":"Khan, M. A. & Palaniyar, N. Transcriptional firing helps to drive NETosis. Sci. Rep. 7, 41749. https:\/\/doi.org\/10.1038\/srep41749 (2017).","journal-title":"Sci. Rep."},{"key":"23076_CR46","doi-asserted-by":"publisher","first-page":"e0157454","DOI":"10.1371\/journal.pone.0157454","volume":"11","author":"G Sollberger","year":"2016","unstructured":"Sollberger, G., Amulic, B. & Zychlinsky, A. Neutrophil extracellular trap formation is independent of de novo gene expression. PLoS ONE 11, e0157454. https:\/\/doi.org\/10.1371\/journal.pone.0157454 (2016).","journal-title":"PLoS ONE"},{"key":"23076_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3389\/fimmu.2019.00423","volume":"10","author":"EA Chapman","year":"2019","unstructured":"Chapman, E. A. et al. Caught in a trap? Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus. Front. Immunol. 10, 423. https:\/\/doi.org\/10.3389\/fimmu.2019.00423 (2019).","journal-title":"Front. Immunol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23076-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23076-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T23:03:25Z","timestamp":1667343805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-23076-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["23076"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-23076-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"15 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.H. has received grants from GlaxoSmithKline. M.O. belongs to the Social Cooperation Program, Department of functional genomics and immunological diseases, supported by Chugai Pharmaceutical, and has received speaking fees from BMS, MSD, and Chugai. Y.T. has received grants from GlaxoSmithKline and speaking fees from GlaxoSmithKline and Chugai. Y.N. belongs to the Social Cooperation Program, Department of functional genomics and immunological diseases, supported by Chugai Pharmaceutical, and has received financial support or fees from BMS, Chugai, GlaxoSmithKline, Kissei, Mitsubishi Tanabe, and Pfizer. T.O. belongs to the Social Cooperation Program, Department of functional genomics and immunological diseases, supported by Chugai Pharmaceutical. H.S. has received speaking fees and grants from Takeda, BMS, Asahi Kasei, Sanofi, Eli Lilly, Janssen, Astellas, Pfizer, Chugai, UCB, Abbvie, Eisai, Boehringer Ingelheim, Gilead, Novartis, and Daiichi-Sankyo. K.F. has received speaking fees, and\/or honoraria from Tanabe Mitsubishi, Bristol Myers, Eli Lilly, Chugai, Jansen, Pfizer, Ono, AbbVie, Ayumi, Astellas, Sanofi, Novartis, Daiichi Sankyo, Eisai, Asahi Kasei, Japan Blood Products Organization, and Kowa, and has received research grants from Tanabe Mitsubishi, Bristol Myers, Eli Lilly, Chugai, AbbVie, Ayumi, Astellas, Sanofi, Eisai, Tsumura and Co., and Asahi Kasei.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18397"}}